Recap: ReWalk Robotics Q3 Earnings

Shares of ReWalk Robotics RWLK decreased 4.2% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share rose 65.22% over the past year to ($0.16), which were in line with the estimate of ($0.16).

Revenue of $747,000 decreased by 39.47% from the same period last year, which missed the estimate of $1,100,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 10, 2020

Time: 08:30 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/ou3s2suj

Recent Stock Performance

Company's 52-week high was at $3.00

52-week low: $0.41

Price action over last quarter: down 11.02%

Company Overview

ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again. The ReWalk systems allow the users to sit, stand, walk, turn and have the ability to climb and descend stairs. It offers two systems, ReWalk Personal which is designed for every day and all day use by individuals at home and in their communities and is custom-fit for each user; and ReWalk Rehabilitation which is designed for the clinical rehabilitation environment where it provides the user with valuable training exercise and therapy. The company generates maximum revenue from the United States and Europe.